138 related articles for article (PubMed ID: 84709)
1. Immunogenicity of chemically induced murine colon cancers.
Belnap LP; Cleveland PH; Colmerauer ME; Barone RM; Pilch YH
Cancer Res; 1979 Apr; 39(4):1174-9. PubMed ID: 84709
[TBL] [Abstract][Full Text] [Related]
2. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.
Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
Cancer Res; 1975 Sep; 35(9):2434-9. PubMed ID: 1149045
[TBL] [Abstract][Full Text] [Related]
3. Transplantation immunity and cross-protection of two cultured murine colon lines.
Sato N; Michaelides MC; Wallack MK
J Natl Cancer Inst; 1983 Feb; 70(2):261-5. PubMed ID: 6571935
[TBL] [Abstract][Full Text] [Related]
4. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer.
Ross DS; Steele G; Madara J; Lahey SJ; Ravikumar TS; Wilson RE; Munroe AE; Wright D; King VP
J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.
Jamasbi RJ; Nettesheim P
Cancer Res; 1977 Nov; 37(11):4059-63. PubMed ID: 71203
[TBL] [Abstract][Full Text] [Related]
6. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
Sato N; Kikuchi K
J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic results obtained with an experimental system oftransplantable colonic tumors. Possible applications of these results to human intestinal tumors].
Martin MS; Martin F
Bull Cancer; 1975; 62(4):439-44. PubMed ID: 174767
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats.
Jamasbi RJ; Nettesheim P; Kennel SJ
Cancer Res; 1978 Feb; 38(2):261-7. PubMed ID: 340026
[TBL] [Abstract][Full Text] [Related]
9. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
Economou GC; Takelchi N; Boone CW
Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
[TBL] [Abstract][Full Text] [Related]
10. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth.
Steele G; Sjogren HO
Surgery; 1977 Jul; 82(1):164-9. PubMed ID: 877853
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumor rejection antigen molecules of chemically induced murine colon tumor C-C26.
Sato N; Yagihashi A; Okubo M; Torigoe T; Takahashi S; Sato T; Kikuchi K
Cancer Res; 1987 Jun; 47(12):3147-51. PubMed ID: 3581064
[TBL] [Abstract][Full Text] [Related]
12. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
[No Abstract] [Full Text] [Related]
13. Protective effect of oral Salmonella enteritidis 11RX infection against colon tumor induction by 1,2-dimethylhydrazine in mice.
Ashman LK; Cook MG; Kotlarski I
Cancer Res; 1979 Jul; 39(7 Pt 1):2768-71. PubMed ID: 376122
[TBL] [Abstract][Full Text] [Related]
14. Current questions on the tumour-associated antigens of chemically-induced tumours II. In search of practical uses.
Oth D
Biomedicine; 1976 Jan; 24(1):4-10. PubMed ID: 57809
[TBL] [Abstract][Full Text] [Related]
15. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
16. B cell response to tumor antigens is associated with depletion of B progenitors in murine colocarcinoma.
Kirman I; Huang EH; Whelan RL
Surgery; 2004 Mar; 135(3):313-8. PubMed ID: 14976482
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
Soloway MS; Martino C; Hyatt C; Marrone JC
Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
[TBL] [Abstract][Full Text] [Related]
18. [Effect of BCG immunotherapy on kinetic parameters and growth curves of 5 transplantable lines of colon carcinoma chemically induced in rat (author's transl)].
Martin MS; Martin F; Justrabo E; Michel MF; Lagneau A
Gastroenterol Clin Biol; 1979 Mar; 3(3):247-53. PubMed ID: 456820
[No Abstract] [Full Text] [Related]
19. Demonstration of effective antitumor immunity in an autochthonous host bearing primary colon tumors induced by 1,2-dimethylhydrazine dihydrochloride.
Bansal BR; Mark R; Mobini J; Rhoads JE; Bansal SC
J Natl Cancer Inst; 1979 Jul; 63(1):127-32. PubMed ID: 312968
[TBL] [Abstract][Full Text] [Related]
20. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
Benrezzak O; Madarnas P; Pageau R; Nigam VN
Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
